May 22, 2024 - AGM & Conference on global trends in research and development
We are pleased to invite you to BIOQuébec's Annual General Meeting 2023, a key event for our members.
The meeting will be followed by a conference and a cocktail reception.
📆 Date: May 22, 2024
🕒 Time: 4 pm to 7:30 pm
📍 Location: Centre PHI, 407 Rue Saint-Pierre, Montreal, QC H2Y 2M3
The conference will focus on global R&D trends and future prospects in healthcare, offered by experts from IQVIA and Deloitte.
Please note that while the Annual General Meeting is reserved for BIOQuébec members in status, the conference and cocktail reception are open to the public. Haven't yet completed your membership? Click here to join.
Program
4:00 to 4:50 pm: Annual General Meeting
5:00 p.m. to 6:00 p.m.: Conference
6:00 p.m. to 7:30 p.m.: Cocktail reception
Deloitte conference: Embracing the Future of Health in Canada through Innovative Partnerships and Paradigm Shits
Ms. Giguère and Ms. Gordana will discuss the role of innovative partnerships and paradigm shifts brought about by industry and the evolution of medicine, and their impact on Canadian healthcare systems.
Geneviève Giguère
Partner - Deloitte
As the partner responsible for our Health Care practice in Quebec and our national Life Sciences practice, Geneviève works with a variety of public and private organizations across Canada to support their digital, operational, and clinical transformations. She is particularly interested in innovative care models, the use of technology to alleviate pressure on the workforce, and ecosystems and partnerships. Previously, she held an executive role in a multinational pharmaceutical organization. Geneviève’s experience across both the health care and pharmaceutical sectors enables her to design and implement large-scale transformations.
Gordana Maric, PhD
Senior Manager, Health and Life Sciences | Consulting - Deloitte
Gordana is a leader in the Deloitte’s healthcare and life sciences consulting practice, focused on guiding life sciences organizations through innovation and transformational change, including new models of care and ecosystem partnerships to bridge patient journey gaps.
She has 10+ years of experience leading large-scale, data-driven, patient-centric transformations for global and local healthcare organizations. Gordana brings expertise in patient-centric health system transformation, strategic planning, evidence-based decision-making and frameworks, Analytics and AI transformations in health, and public private partnerships, through her experience advising public and private stakeholders across the Canadian healthcare (e.g., pharmaceutical companies, hospitals, public health organizations, etc.).
Gordana holds a PhD from McGill University in Medicine with a focus on precision Oncology. She specialized in precision medicine by developing genomic and proteomic-based approaches to identify and validate therapeutic targets for breast cancer disease management. Gordana also holds a Bachelor of Science from the University of Toronto.
IQVIA conference : Global R&D trends
Mr. Omoto will present the annual Global Research Trends 2024 report, which covers worldwide trends in the launch of new therapies and clinical trials. It also profiles the state of R&D funding and corporate activity of various types.
Mark Omoto
General Manager, Thought Leadership, Marketing & Communications, Canada - IQVIA
As General Manager at IQVIA Canada, Mark oversees IQVIA’s thought leadership strategy and initiatives, and leads its marketing and corporate communications teams.
He also provides consulting leadership to companies in the pharmaceutical, biotech, and government sectors across IQVIA’s Consulting, Analytics, Market Access, and Technology Solutions.
Mark has held senior roles as President, and Vice President Commercial at several leading pharmaceutical, biotech, technology, and start-up companies.
A business leader with more than 25 years of experience in the pharmaceutical, information technology, and consulting sectors, Mark brings product launch, market access and global marketing expertise across multiple therapeutic areas to his work at IQVIA.
